Skip to main content
FinSpry Logo
FinSpry
HLN logo
HLN
(NYSE)
Haleon plc
$9.93-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Haleon (HLN) Stock Price & Financial Analysis

Haleon Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.87 - $10.00
52-Week High$11.42
52-Week Low$8.71
Open$9.91
Volume4.75M
Average Volume (3M)4.75M
Market Cap44.50B
Shares Outstanding4.48B
P/E Ratio (TTM)14.20
Forward P/E10.13
Price to Sales (P/S)2.04
Price to Book (P/B)2.06
EV/EBITDA10.41
Revenue (TTM)21.82B
Net Income (TTM)3.14B
Free Cash Flow (TTM)3.03B
EPS (TTM)$0.70
Profit Margin14.38%
Operating Margin21.22%
Return on Equity (ROE)14.50%
Debt to Equity0.52
50-Day MA$10.50
200-Day MA$9.87
52-Week Change-2.06%
Annual Dividend$0.18
Dividend Yield1.77%
Payout Ratio25.07%
Last Dividend Ex-DateSep 18, 2026

Frequently Asked Questions About Haleon

What is the current stock price for HLN?

As of the latest trading session, HLN stock trades at $9.93. The 52-week range is $8.71–$11.42, with a day range of $9.87–$10.00.

What is the P/E ratio for HLN?

Haleon's trailing P/E ratio is 14.2, meaning investors pay $14.2 for every $1 of annual earnings. The forward P/E is 10.1, reflecting analyst expectations for future earnings. Haleon operates in the Healthcare sector.

Does HLN pay dividends?

Yes, Haleon pays a 1.77% annual dividend yield ($0.18 per share). The payout ratio is 25.1%. The last ex-dividend date was 2026-09-18.

What do analysts recommend for HLN?

Based on 1 analyst, the consensus for HLN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HLN?

Haleon's market capitalization is $44.50B, classifying it as a large-cap company. Haleon operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.